State TN
Clinical Trials in Tennessee
Recruiting clinical trials with at least one study location in Tennessee. Data updated daily from ClinicalTrials.gov.
Top Conditions in Tennessee
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
NCT07307664 N/A
Recruiting
Increasing Germline Genetic Testing for Patients With Cancer
Condition
Hereditary Pancreatic Cancer
Enrollment
1,000 pts
Location
United States
Sponsor
Josh Peterson
NCT06991114 Phase 2
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Ther...
Condition
Refractory Rheumatoid Arthritis (RA)
Enrollment
90 pts
Location
United States, Bulgaria, France
Sponsor
Artiva Biotherapeutics, Inc.
NCT06701214 N/A
Recruiting
The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepositor...
Condition
Clonal Hematopoiesis
Enrollment
800 pts
Location
United States
Sponsor
Vanderbilt-Ingram Cancer Cente
NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT05787587 Phase 1
Recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Condition
Advanced or Metastatic Solid Tumors
Enrollment
216 pts
Location
United States
Sponsor
IDEAYA Biosciences
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell M...
Condition
B-cell Malignancy
Enrollment
614 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
NCT06808984 Phase 2
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the ...
Condition
Agitation
Enrollment
120 pts
Location
United States
Sponsor
Celgene
NCT06575192 Phase 3
Recruiting
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix...
Condition
Breast Reconstruction
Enrollment
783 pts
Location
United States
Sponsor
AbbVie
NCT06699121 Phase 2
Recruiting
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
Condition
Primary Sclerosing Cholangitis (PSC)
Enrollment
87 pts
Location
United States
Sponsor
LISCure Biosciences
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07400588 Phase 2
Recruiting
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
Condition
Obese
Enrollment
50 pts
Location
United States
Sponsor
Gasherbrum Bio, Inc., a wholly
NCT06823167 Phase 1
Recruiting
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Condition
Solid Malignancies
Enrollment
117 pts
Location
United States, Spain
Sponsor
Immunome, Inc.
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Antic...
Condition
Atrial Fibrillation (AF)
Enrollment
1,200 pts
Location
United States, Canada
Sponsor
Regeneron Pharmaceuticals
NCT05234567 N/A
Recruiting
A Prospective Sub-Study of the Global Hypophosphatasia Registry
Condition
Hypophosphatasia
Enrollment
30 pts
Location
United States
Sponsor
Alexion Pharmaceuticals, Inc.
NCT06533059 Phase 1
Recruiting
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant S...
Condition
Cancer
Enrollment
110 pts
Location
United States, Australia, France
Sponsor
Alterome Therapeutics, Inc.
NCT06792695 Phase 2
Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Color...
Condition
Metastatic Colorectal Cancer
Enrollment
120 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT04967989 Phase 3
Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
Condition
Glaucoma and Ocular Hypertension
Enrollment
790 pts
Location
United States, Canada
Sponsor
University of Pittsburgh
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT05140941 Phase 4
Recruiting
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
Condition
Hepatitis C, Chronic
Enrollment
100 pts
Location
United States, Canada
Sponsor
Catherine Anne Chappell
NCT07276997 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcapr...
Condition
Major Depressive Disorder
Enrollment
195 pts
Location
United States
Sponsor
AbbVie
NCT05889624 N/A
Recruiting
Responding With Evidence and Access for Childhood Headaches
Condition
Headache
Enrollment
400 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT05919680 Phase 2
Recruiting
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease...
Condition
Intestinal Failure Associated Liver Disease
Enrollment
36 pts
Location
United States
Sponsor
NorthSea Therapeutics B.V.
Page 1 of 11 — 264 trials total